AML Research Updates: News from ASH 2020 episode artwork

EPISODE · Mar 31, 2021 · 15 MIN

AML Research Updates: News from ASH 2020

from Empowered! · host Patient Empowerment Network

AML expert Dr. Jeffrey Lancet shares news from the 2020 American Society of Hematology (ASH) annual meeting. Dr. Lancet sheds light on headlines from the meeting including FLT3 inhibitor research, combination therapies with venetoclax, a promising inhibitor therapy, and shares his optimism about the future of AML treatment.About the Guest: Dr. Jeffrey Lancet is Chair and Program Lead in the Department of Malignant Hematology at Moffitt Cancer Center in Tampa, FL. He is nationally and internationally recognized for his clinical research in the field of acute leukemias. Learn more about Dr. Lancet, here.

Episode metadata supplied by the publisher feed · Published Mar 31, 2021

Embed this episode

Ready to play

AML Research Updates: News from ASH 2020

0:00 15:03

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of Empowered!?

This episode is 15 minutes long.

When was this Empowered! episode published?

This episode was published on March 31, 2021.

Can I download this Empowered! episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!